Enorama Pharma AB (ERMA)

Currency in SEK
2.690
+0.300(+12.55%)
Closed·
ERMA Scorecard
Full Analysis
Significant return over the last week
ERMA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.3002.690
52 wk Range
1.5158.480
Key Statistics
Prev. Close
2.69
Open
2.3
Day's Range
2.3-2.69
52 wk Range
1.515-8.48
Volume
47
Average Volume (3m)
13.04K
1-Year Change
-47.87%
Book Value / Share
0.15
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ERMA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Enorama Pharma AB Company Profile

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company was incorporated in 2006 and is based in Malmö, Sweden.

Employees
5
Market
Sweden

Compare ERMA to Peers and Sector

Metrics to compare
ERMA
Peers
Sector
Relationship
P/E Ratio
−2.6x0.0x−0.5x
PEG Ratio
−0.200.000.00
Price/Book
16.6x0.0x2.6x
Price / LTM Sales
9.5x0.0x3.2x
Upside (Analyst Target)
-0.0%41.9%
Fair Value Upside
Unlock0.0%4.3%Unlock

Earnings

Latest Release
May 21, 2025
EPS / Forecast
-0.37 / --
Revenue / Forecast
449.00K / --
EPS Revisions
Last 90 days

ERMA Income Statement

FAQ

What Stock Exchange Does Enorama Pharma Trade On?

Enorama Pharma is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Enorama Pharma?

The stock symbol for Enorama Pharma is "ERMA."

What Is the Enorama Pharma Market Cap?

As of today, Enorama Pharma market cap is 180.60M.

What Is Enorama Pharma's Earnings Per Share (TTM)?

The Enorama Pharma EPS (TTM) is -1.02.

From a Technical Analysis Perspective, Is ERMA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Enorama Pharma Stock Split?

Enorama Pharma has split 1 times.

How Many Employees Does Enorama Pharma Have?

Enorama Pharma has 5 employees.

What is the current trading status of Enorama Pharma (ERMA)?

As of 24 Jul 2025, Enorama Pharma (ERMA) is trading at a price of 2.69, with a previous close of 2.69. The stock has fluctuated within a day range of 2.30 to 2.69, while its 52-week range spans from 1.52 to 8.48.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.